Back

Tumour necrosis factor receptor 1 inhibition and cardiovascular disease: a cis-Mendelian randomization study

13 April 2023 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Young Investigators Award - Population Science and Public Health Cardiovascular Epidemiology EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Doctor Skanda Rajasundaram

University of Oxford and Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Outcome of a nationwide screening programme in young individuals
Doctor H. MacLachlan (London, GB)
Abstract Slides Video
Presentation thumbnail
Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland
Doctor A. Alkandari (Kuwait City, KW)
Abstract Slides Video
Presentation thumbnail
Novel insights into cardiovascular ageing in the general population using machine learning
Doctor M. Shah (London, GB)
Abstract Slides Video
Presentation thumbnail
External validation of Systematic COronary Risk Evaluation 2 - Older Persons (SCORE2-OP) in the EPIC-Norfolk prospective population study
Ms T. Van Trier (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigators Award - Population Science and Public Health
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April - 15 April 2023
You may be interested in
thumbnail
Congress Presentation
From rheumatology to cardiology: biologic insights into cardiovascular disease
thumbnail
Congress Presentation
State-of-the-art lecture on inflammation and cardiovascular disease
thumbnail
Congress Presentation
Anti-inflammatory agents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources